Armata Pharmaceuticals Inc (A:ARMP)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for ARMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Innoviva, Inc. Direct Ownership Warrants to Purchase Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 14/20 Innoviva, Inc. Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 12/20 Odysseas Kostas D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
Feb 14/20 Feb 12/20 Schlesinger Sarah J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
Oct 15/19 Oct 10/19 Peterson Todd C. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Cook Jeremy Curnock Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Bear Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Martin Steven Robert Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 149,362  
May 24/19 May 22/19 Patrick Todd Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 298,724  
May 24/19 May 22/19 Morris Duane Alfred Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 74,681  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ARMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 21st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 14/20 Feb 14/20 Innoviva, Inc. Direct Ownership Warrants to Purchase Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 14/20 Innoviva, Inc. Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Feb 14/20 Feb 12/20 Odysseas Kostas D Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
Feb 14/20 Feb 12/20 Schlesinger Sarah J. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
Feb 14/20 May 9/19 Cook Jeremy Curnock Indirect Ownership Warrant to Purchase Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -46,666 $12,065.46
Feb 14/20 May 9/19 Perry Michael S Indirect Ownership Warrant to Purchase Common Stock Form 5 : Annual Statement of Beneficial Ownership of Securities -46,666 $12,065.46
Oct 15/19 Oct 10/19 Peterson Todd C. Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Cook Jeremy Curnock Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Bear Richard Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 27,383  
May 24/19 May 22/19 Martin Steven Robert Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 149,362  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ARMP

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Alnylam Pharmaceuticals (OQ:ALNY)
Vir Biotechnology (OQ:VIR)